About Enzene Biosciences Limited
Data last updated:
Enzene Biosciences Limited is a public limited company based in Pune, Maharashtra, India, a subsidiary of Alkem Laboratories Limited. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 28 August 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232PN2006PLC165610. Its GSTIN is 27AABCE6662L1ZA (Maharashtra). The company holds 6 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹66 Cr and a paid-up capital of ₹58.45 Cr. It was formerly known as Enzene Biosciences Private Limited. It is led by directors including Himanshu Shashikant Gadgil (Whole-Time Director) and Sangeeta Kapil Jit Singh.
Its last annual general meeting (AGM) was held on 21 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Plot No A 22 A/1/2 Chakan Industrial Area Phase 2 Khalumbre Chakan, Pune, Maharashtra, India – 410501.
As per the financials filed for FY 2026, the company reported a revenue of ₹468.32 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net loss of ₹150.49 Cr (net margin -32.1%) and EBITDA of -₹43.3 Cr (EBITDA margin -9.2%). Revenue has grown at a compounded annual rate (CAGR) of 50% over three years.
The company has about 665 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Enzene Biosciences. As per MCA filings, the company has open charges of ₹157.37 Cr and satisfied charges of ₹137.95 Cr on record. Court records list 7 cases involving the company, including 5 filed by the company and 2 filed against it; 5 cases are pending. The company has 22 deals on record (8 rights issues, 6 funding rounds, 6 secondary share transfers), with disclosed funding of ₹437.67 Cr; the latest was in January 2023. The company has 12 MSME Form 1 returns on record between 2019 and 2024, listing 100 overdue payments to 20 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website enzene.com.
Company details
CIN history
Enzene Biosciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24232PN2006PLC165610, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232PN2006PLC165610 | Current |
| U24232KA2006PTC040295 | Previous |
| U24232KA2006PLC040295 | Previous |
Contact details
Enzene Biosciences Limited's registered office is in Pune, Maharashtra. Its website is enzene.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No A 22 A/1/2 Chakan Industrial Area Phase 2 Khalumbre Chakan, Pune, Maharashtra, India – 410501
- IndustryLife Sciences, Biotechnology
To see the full contact details of Enzene Biosciences Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Enzene Biosciences operates one associated brand: Enzene Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Company specializing in development of Biosimilars | enzene.com |
Business activity
The main business activity of Enzene Biosciences is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Enzene Biosciences Limited, buy the company report.
Financials of Enzene Biosciences Limited
FY 2026 filings availableEnzene Biosciences Limited reported revenue of ₹468.32 Cr (up 33% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 50% over three years, including 33% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹468.32 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹43.3 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹150.49 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.2% | ||||
| Net Profit Margin | -32.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Enzene Biosciences Limited, buy the company report.
Board of directors of Enzene Biosciences Limited
Enzene Biosciences has 9 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sangeeta Kapil Jit Singh Also directs: Laxmi Organic Industries Limited, Galaxy Surfactants Ltd, Shaily Engineering Plastics Limited and 4 more | Director | 02 Aug 2022 | 4 Years 3 Months | Current |
| Sandeep Singh | Director | 20 Oct 2011 | 15 Years 0 Months | Current |
| Himanshu Shashikant Gadgil | Whole-Time Director | 09 Feb 2017 | 9 Years 8 Months | Current |
| Prem Pavoor Also directs: Laurus Bio Private Limited, Immuneel Therapeutics Private Limited, Caplin Steriles Limited and 3 more | Director | 30 Jan 2023 | 3 Years 9 Months | Current |
| Aniruddha Singh Also directs: Alkem Wellness Limited, Alkem Medtech Private Limited, Adroit Biomed Limited and 3 more | Director | 07 Mar 2025 | 1 Years 8 Months | Current |
| Ketan Mahendra Patel Also directs: Caplin Steriles Limited | Director | 22 May 2026 | 0 Years 5 Months | Current |
Auditor
Enzene Biosciences Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells LLP | FY 2026 | 117366W/W-100018 |
Shareholding
The shareholding of Enzene Biosciences Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Enzene Biosciences Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Feb 2024 | 100870031 | Others | ₹80 Cr | Open | |
| 31 May 2018 | 100185622 | Axis Bank Limited | ₹77.12 Cr | Open | |
| 28 Mar 2018 | 100191877 | Hdfc Bank Limited | ₹25 Lakh | Open | |
| 16 Dec 2022 | 100699653 | Others | ₹43.75 Cr | Satisfied | |
| 19 Apr 2017 | 100110074 | Axis Bank Limited | ₹45.14 Cr | Satisfied |
To see the full charge records of Enzene Biosciences Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Enzene Biosciences Limited has 22 deals on record (8 rights issues, 6 funding rounds, 6 secondary share transfers), with disclosed funding of ₹437.67 Cr; the latest was in January 2023.
Deals on record (5 of 22)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2022 | Rights issue | ₹250 Cr | Investors: Alkem Laboratories Limited |
| Jul 2021 | Rights issue | ₹50 Cr | Investors: Alkem Laboratories Limited |
| May 2021 | Rights issue | ₹10 Cr | Investors: Alkem Laboratories Limited |
| Feb 2021 | Rights issue | ₹40 Cr | Investors: Alkem Laboratories Limited |
| Jun 2020 | Rights issue | ₹50 Cr | Investors: Alkem Laboratories Limited |
To see the full deal history of Enzene Biosciences Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Enzene Biosciences Limited has 7 court cases on record: 5 filed by Enzene Biosciences, 2 filed against it. 5 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 4 |
| District courts | 2 | 1 | 1 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed by the company against Kunal Facilities India Pvt. Ltd THR. Its Authorised Representative and 1 other | Pending |
| Supreme Court | Appeal | Filed against the company by Pune and 1 other | Disposed |
| District court, South West, Delhi | Commercial suit | Filed against the company by Bioelite Lifesciences Pvt. Ltd. | Disposed |
| District court, Pune, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
| Bombay High Court | Writ petition | Filed by the company against State of Maharashtra THR Government Pleader and Ors | Pending |
To see the full case history of Enzene Biosciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Enzene Biosciences Limited has 12 MSME Form 1 returns on record between 2019 and 2024, listing 100 overdue payments to 20 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 20)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Radhan Plastics Private Limited | |||
| Verify Credentials | |||
| Hundredone Sports & Events Private Limited | |||
| Intech Analytical Instruments | |||
| an individual supplier |
To see the full MSME payment records of Enzene Biosciences Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Enzene Biosciences Limited has a workforce of 665 employees on its EPFO records as of Dec 25, 2025, across 2 active EPFO establishments.
GST
Enzene Biosciences has 6 GST registrations: 4 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCE6662L1ZA | Maharashtra | Active | 01 Jul 2017 |
| 36AABCE6662L1ZB | Telangana | Active | 29 Jun 2024 |
| 19AABCE6662L1Z7 | West Bengal | Active | 08 Jul 2024 |
| 09AABCE6662L1Z8 | Uttar Pradesh | Active | 10 Jul 2024 |
To see the full GST registrations and return filing status of Enzene Biosciences Limited, buy the company report.
Recent activity
Enzene Biosciences Limited has 24 board changes on record since 2011: 11 appointments and 13 cessations. The latest: Ketan Mahendra Patel was appointed as Director on 22 May 2026.
31 earlier events are in the company report.
News
Frequently asked questions
Enzene Biosciences is an active public limited company based in Pune, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 28 August 2006 (20+ years old) and is registered under CIN U24232PN2006PLC165610.
Enzene Biosciences has 9 current directors:
- Himanshu Shashikant Gadgil - Whole-Time Director
- Sangeeta Kapil Jit Singh - Director
- Sandeep Singh - Director
- Prem Pavoor - Director
- Aniruddha Singh - Director
- Ketan Mahendra Patel - Director
- Narendra Kumar Aneja - Director
- Mritunjay Kumar Singh - Director
- Srinivas Balmiki Prasad Singh - Director
The latest financial statements of Enzene Biosciences on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 21 August 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Enzene Biosciences is 27AABCE6662L1ZA, registered in Maharashtra. The company has 6 GST registrations in all, of which 4 are active and 2 are cancelled or inactive. Other active GSTINs include 36AABCE6662L1ZB (Telangana), 19AABCE6662L1Z7 (West Bengal), 09AABCE6662L1Z8 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Enzene Biosciences is U24232PN2006PLC165610. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Enzene Biosciences has 7 court cases on record: 5 filed by the company and 2 filed against it. 5 are pending. Most are in the high courts.
Enzene Biosciences was incorporated on 28 August 2006, making it 20+ years old. It is registered with the Registrar of Companies, Pune.
Enzene Biosciences has 22 deals on record (8 rights issues, 6 funding rounds, 6 secondary share transfers), with disclosed funding of ₹437.67 Cr; the latest was in January 2023.
Ketan Mahendra Patel was appointed as Director on 22 May 2026. Mritunjay Kumar Singh was appointed as Director on 22 May 2026. Narendra Kumar Aneja was appointed as Director on 22 May 2026. Enzene Biosciences has 24 board changes on record in total.
Enzene Biosciences has 12 MSME Form 1 returns on record between 2019 and 2024, listing 100 overdue payments to 20 micro and small suppliers. The latest return was filed on 26 Apr 2024.
Enzene Biosciences can be reached through the website enzene.com. Its registered office is in Pune, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
